Syntocinon is one of 121 small molecule programs targeting Cesarean Section. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
83 competitors in Cesarean Section
Fentanyl-Morphine
Acetaminophen/ibuprofen
Ondansetron, Dexamethasone
Morphine - .
Sebacoyl Dinalbuphine Ester
Proamatine
Dynastat
Duragesic
Versed
Catapres
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details